Premium
CO‐CBS‐H 2 S Axis: From Vascular Mediator to Cancer Regulator
Author(s) -
Suematsu Makoto,
Nakamura Takashi,
Tokumoto Yasuhito,
Yamamoto Takehiro,
Kajimura Mayumi,
Kabe Yasuaki
Publication year - 2016
Publication title -
microcirculation
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.793
H-Index - 83
eISSN - 1549-8719
pISSN - 1073-9688
DOI - 10.1111/micc.12253
Subject(s) - pentose phosphate pathway , regulator , mediator , enzyme , chemistry , microbiology and biotechnology , biochemistry , heme , dilator , glycolysis , cancer cell , biology , cancer , medicine , genetics , gene
CO is a gaseous mediator generated by HO. Our previous studies revealed that CO generated from inducible HO‐1 or from constitutive HO‐2 modulates function of different heme proteins or enzymes through binding to their prosthetic ferrous heme to alter their structures, regulating biological function of cells and organs. Such CO‐directed target macromolecules include sGC and CBS. In the liver, CO serves as a sinusoidal dilator through its action on sGC in hepatic stellate cells, while the same gas accounts for vasoconstrictor that inhibits H 2 S generated by CO‐sensitive CBS in astrocytes. Since molecular O 2 is a substrate for HO, the latter mechanism contributes to hypoxic vasodilation in neurovascular units. We have recently uncovered that stress‐inducible CO in and around cancer cells suppresses CBS to result in decreased methylation of PFKFB3, the enzyme regulating PFK‐1, leading to a shift of glucose biotransformation from glycolysis toward pentose phosphate pathway; such a metabolic remodeling causes chemoresistance through increasing NADPH and reduced glutathione under stress conditions for cancer cells. This article reviews the intriguing networks of CO‐sensitive metabolic regulatory mechanisms in microcirculation and cancer.